FDA Guidance Aims to Reduce Adhesion Failures of Generic Patches
This article was originally published in The Gold Sheet
FDA aims to help manufacturers improve the adhesive qualities of transdermal patches in a new guidance. Agency official says that poor adhesion is a major quality problem with these patches and has been the source of numerous recalls.
Register for our free email digests: